Literature DB >> 7252524

Relationship of in vitro morphologic and growth characteristics of established human glioma-derived cell lines to their tumorigenicity in athymic nude mice.

S H Bigner, D E Bullard, C N Pegram, C J Wikstrand, D D Bigner.   

Abstract

Fifteen permanent cell lines derived from human gliomas which are individually distinct by immunologic and biochemical criteria were evaluated to determine if morphologic or cell biologic parameters distinguished the 4 lines which were tumorigenic in athymic nude mice. By subjective morphologic appraisal, the 4 tumorigenic lines were considered "malignant" or "borderline," but 4 of the non-tumorigenic lines were also classified in this way. By objective criteria, these 15 lines varied markedly in percentage of piled-up cells, chromatin pattern, pleomorphism, nuclear to cytoplasmic ratio, number of bizarre multinucleate giant cells, presence of abnormal mitotic figures, percentage of colony formation in soft agar, saturation density, population doubling time, and absolute plating efficiency. Among these criteria, percentage of colony formation in soft agar had the highest correlation coefficiency with tumorigenicity, and when this parameter was held constant the only additional characteristic which correlated significantly (p less than .05) was the number of bizarre multinucleate giant cells. When the 11 non-tumorigenic lines were ranked by these 2 criteria, 1 non-tumorigenic line (U-251 MGsp) had greater than .95 predicted probability of tumorigenicity. Although further tumorigenicity testing may increase the number of tumorigenic lines, the lines with few "malignant" characteristics may correspond to the population resembling cells of low grade astrocytomas seen within glioblastomas. The histologic pleomorphism of human gliomas is reflected in their morphologic and cell biologic diversity in culture.

Entities:  

Mesh:

Year:  1981        PMID: 7252524     DOI: 10.1097/00005072-198107000-00004

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  24 in total

1.  Establishment and characterization of five cell lines derived from human malignant gliomas.

Authors:  J T Rutka; J R Giblin; D Y Dougherty; H C Liu; J R McCulloch; C W Bell; R S Stern; C B Wilson; M L Rosenblum
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

2.  Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell-based therapeutics.

Authors:  Jian Gang Zhang; Junichi Eguchi; Carol A Kruse; German G Gomez; Habib Fakhrai; Stephanie Schroter; Wenxue Ma; Neil Hoa; Boris Minev; Christina Delgado; H Terry Wepsic; Hideho Okada; Martin R Jadus
Journal:  Clin Cancer Res       Date:  2007-01-15       Impact factor: 12.531

3.  Spontaneous phenotypic and karyotypic progression in the SV40 transfected cell line SVG during prolonged passage in vitro.

Authors:  P Davey; A M Rauth; L Mason; L Addy
Journal:  J Neurooncol       Date:  1990-02       Impact factor: 4.130

4.  In vivo growth conditions suppress the expression of ganglioside GM2 and favour that of lacto series gangliosides in the human glioma D-54MG cell line.

Authors:  P Fredman; C J Wikstrand; J E Månsson; G Reifenberger; S H Bigner; A Rasheed; L Svennerholm; D D Bigner
Journal:  Glycoconj J       Date:  1996-06       Impact factor: 2.916

5.  PEGylated peptide to TIP1 is a novel targeting agent that binds specifically to various cancers in vivo.

Authors:  Vaishali Kapoor; Abhay Kumar Singh; Buck E Rogers; Dinesh Thotala; Dennis E Hallahan
Journal:  J Control Release       Date:  2019-02-11       Impact factor: 9.776

6.  Growth effects of epidermal growth factor (EGF) and a monoclonal antibody against the EGF receptor on four glioma cell lines.

Authors:  M H Werner; P A Humphrey; D D Bigner; S H Bigner
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

7.  Morphologic, cytochemical and neurochemical characterization of the human medulloblastoma cell line TE671.

Authors:  P M Zeltzer; S L Schneider; D D Von Hoff
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

Review 8.  Invasiveness of primary brain tumors.

Authors:  O D Laerum; R Bjerkvig; S K Steinsvåg; L de Ridder
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

9.  Tumor-Specific Binding of Radiolabeled PEGylated GIRLRG Peptide: A Novel Agent for Targeting Cancers.

Authors:  Vaishali Kapoor; David Y A Dadey; Kim Nguyen; Scott A Wildman; Kelly Hoye; Arpine Khudanyan; Nilantha Bandara; Buck E Rogers; Dinesh Thotala; Dennis E Hallahan
Journal:  J Nucl Med       Date:  2016-07-21       Impact factor: 10.057

10.  Characterization of a continuous human glioma cell line DBTRG-05MG: growth kinetics, karyotype, receptor expression, and tumor suppressor gene analyses.

Authors:  C A Kruse; D H Mitchell; B K Kleinschmidt-DeMasters; W A Franklin; H G Morse; E B Spector; K O Lillehei
Journal:  In Vitro Cell Dev Biol       Date:  1992 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.